Pulike Biological Engineering,Inc. (China)

Pulike Biological Engineering, Inc. is a company located in Luoyang, China. The company specializes in the research, production, and sales of veterinary drugs. Their main products include veterinary biological products and veterinary chemical drugs. Pulike Biological Engineering, Inc. has achieved stable growth in assets, income, and profitability, making it one of the leading companies in the domestic veterinary drug industry. The company has developed international and domestic industry-leading or advanced technological advantages in various areas such as vaccine strain purification technology, cell cloning technology, novel adjuvants for vaccines, multi-component and multi-valent vaccine technology, genetic engineering vaccine technology, chemical synthesis (semi-synthesis) drugs, and new drug formulations. They have successfully launched and promoted a series of new products with high technological content and high market demand, establishing a leading market position for their main products. Some of their main products, such as the New-Branch-Stream trivalent inactivated vaccine, New-Branch-Reduce-Stream quadrivalent inactivated vaccine, chicken infectious bursal disease refined egg yolk antibody, and duck viral hepatitis refined egg yolk antibody, hold a significant market share in their respective segments.